98 related articles for article (PubMed ID: 15185343)
1. Altered mode of allelic replication accompanied by aneuploidy in peripheral blood lymphocytes of prostate cancer patients.
Dotan ZA; Dotan A; Ramon J; Avivi L
Int J Cancer; 2004 Aug; 111(1):60-6. PubMed ID: 15185343
[TBL] [Abstract][Full Text] [Related]
2. Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.
Dotan ZA; Dotan A; Ramon J; Avivi L
BMC Cancer; 2008 Dec; 8():390. PubMed ID: 19109880
[TBL] [Abstract][Full Text] [Related]
3. Modification in the inherent mode of allelic replication in lymphocytes of patients suffering from renal cell carcinoma: a novel genetic alteration associated with malignancy.
Dotan ZA; Dotan A; Litmanovitch T; Ravia Y; Oniashvili N; Leibovitch I; Ramon J; Avivi L
Genes Chromosomes Cancer; 2000 Mar; 27(3):270-7. PubMed ID: 10679916
[TBL] [Abstract][Full Text] [Related]
4. Allele-specific replication associated with aneuploidy in blood cells of patients with hematologic malignancies.
Korenstein-Ilan A; Amiel A; Lalezari S; Lishner M; Avivi L
Cancer Genet Cytogenet; 2002 Dec; 139(2):97-103. PubMed ID: 12550768
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells.
Nagler A; Korenstein-Ilan A; Amiel A; Avivi L
Exp Hematol; 2004 Jan; 32(1):122-30. PubMed ID: 14725909
[TBL] [Abstract][Full Text] [Related]
6. Asynchronous DNA replication and aneuploidy in lymphocytes of hepatocellular carcinoma patients.
Hanna MO; Zayed NA; Darwish H; Girgis SI
Cancer Genet; 2012 Dec; 205(12):636-43. PubMed ID: 23182962
[TBL] [Abstract][Full Text] [Related]
7. Aneuploidy of chromosome Y in prostate tumors and seminal vesicles: a possible sign of aging rather than an indicator of carcinogenesis?
Nadal M; Pera G; Pujadas J; Abril J; González L; Aguiló F; Condom E; Gómez-Zaera M; Nunes V
Mol Carcinog; 2007 Jul; 46(7):543-52. PubMed ID: 17295237
[TBL] [Abstract][Full Text] [Related]
8. The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantation.
Nagler A; Cytron S; Mashevich M; Korenstein-Ilan A; Avivi L
BMC Cancer; 2010 May; 10():230. PubMed ID: 20497575
[TBL] [Abstract][Full Text] [Related]
9. Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients.
Grinberg-Rashi H; Cytron S; Gelman-Kohan Z; Litmanovitch T; Avivi L
Neoplasia; 2010 Aug; 12(8):668-74. PubMed ID: 20689761
[TBL] [Abstract][Full Text] [Related]
10. Modified allelic replication in lymphocytes of patients with neurofibromatosis type 1.
Reish O; Orlovski A; Mashevitz M; Sher C; Libman V; Rosenblat M; Avivi L
Cancer Genet Cytogenet; 2003 Jun; 143(2):133-9. PubMed ID: 12781447
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic analyses in blood cells of men suspected of prostate cancer predict the outcome of biopsy better than serum PSA levels.
Cytron S; Stepnov E; Bounkin I; Mashevich M; Dotan A; Avivi L
Clin Epigenetics; 2011 Aug; 2(2):383-388. PubMed ID: 21949550
[TBL] [Abstract][Full Text] [Related]
12. Asynchronous replication of homologous alpha-satellite DNA loci in man is associated with nondisjunction.
Litmanovitch T; Altaras MM; Dotan A; Avivi L
Cytogenet Cell Genet; 1998; 81(1):26-35. PubMed ID: 9691171
[TBL] [Abstract][Full Text] [Related]
13. Replication timing regulation in adults with chromosomal balance rearrangements.
Xie Y; Wu J; Lin S; Zhou Y; Fang Q; Sun X
Genet Mol Res; 2015 Jul; 14(3):7833-40. PubMed ID: 26214464
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
[TBL] [Abstract][Full Text] [Related]
16. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
17. Altered methylation of multiple genes in carcinogenesis of the prostate.
Yamanaka M; Watanabe M; Yamada Y; Takagi A; Murata T; Takahashi H; Suzuki H; Ito H; Tsukino H; Katoh T; Sugimura Y; Shiraishi T
Int J Cancer; 2003 Sep; 106(3):382-7. PubMed ID: 12845678
[TBL] [Abstract][Full Text] [Related]
18. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
[TBL] [Abstract][Full Text] [Related]
19. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
20. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
Zambra FM; Biolchi V; Brum IS; Chies JA
Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
